Skip to main content
CivicGate

HB 364 DE
Became Law

AN ACT TO AMEND TITLE 18 OF THE DELAWARE CODE RELATING TO CANCER COVERAGE.

DE · session 152 · Assembly / House · bill

A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →

Introduced Apr 11, 2024

Latest action (Aug 2, 2024) Signed by Governor

Summary

This Act requires that individual, blanket, and group health insurance carriers cover drug treatment for the associated conditions of metastatic cancer in the same way treatment for metastatic cancer is covered. Specifically, it requires insurance companies to cover any FDA approved drug prescribed to treat the side effects of metastatic cancer treatment and prohibits insurance companies from mandating that patients first fail to respond to a different drug or prove a history of failure of such drug. Technical changes are also made to comply with the Delaware Legislative Drafting Manual.

Sponsors (13)

Action history (7)

  1. Apr 11, 2024 Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House · lower
  2. Apr 16, 2024 Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 5 Favorable, 4 On Its Merits · lower
  3. Jun 11, 2024 Passed By House. Votes: 39 YES 2 ABSENT · lower
  4. Jun 11, 2024 Assigned to Banking, Business, Insurance & Technology Committee in Senate · upper
  5. Jun 18, 2024 Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 1 Favorable, 5 On Its Merits · upper
  6. Jun 25, 2024 Passed By Senate. Votes: 21 YES · upper
  7. Aug 2, 2024 Signed by Governor · executive

Full text

The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.

Comments

Comments

Loading comments…

Data from OpenStates. View on OpenStates →